<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7016755/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Calcium channels/pumps utilized by a virus.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Cellular Targets</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Virus</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Consequences [Ref.]</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">VGCCs</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ca 
    <sub>V</sub>1.2 serves as a host cell surface receptor that binds IAV and is critical for IAV entry [ 
    <a rid="B9-cells-09-00094" ref-type="bibr">9</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SFTSV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Benidipine hydrochloride, VGCC blocker, inhibits SFTSV infection via impairing virus internalization and genome replication [ 
    <a rid="B12-cells-09-00094" ref-type="bibr">12</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NWV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Virus binds to VGCCs and promotes virus entry at the virus–cell fusion step [ 
    <a rid="B13-cells-09-00094" ref-type="bibr">13</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavivirus (JEV, ZIKV, DENV, and WNV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VGCCs blockers inhibit flavivirus (JEV, ZIKV, DENV and WNV) infection at the stage of replication [ 
    <a rid="B14-cells-09-00094" ref-type="bibr">14</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat/gp120 overactivate VGCCs [ 
    <a rid="B15-cells-09-00094" ref-type="bibr">15</a>, 
    <a rid="B16-cells-09-00094" ref-type="bibr">16</a>, 
    <a rid="B17-cells-09-00094" ref-type="bibr">17</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-1 downregulates the Ca 
    <sub>V</sub>3.2 channel and diminishes the detection of viral infection by host [ 
    <a rid="B19-cells-09-00094" ref-type="bibr">19</a>, 
    <a rid="B20-cells-09-00094" ref-type="bibr">20</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TPCs</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EBOV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Facilitates virus–endosome membrane fusion and releases of virus capsid into the cell cytoplasm [ 
    <a rid="B27-cells-09-00094" ref-type="bibr">27</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STIM1/ORAI1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EBOV, MARV, LASV, JUNV, HIV-1, DENV, and HBV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promote virion assembly and budding [ 
    <a rid="B35-cells-09-00094" ref-type="bibr">35</a>, 
    <a rid="B36-cells-09-00094" ref-type="bibr">36</a>, 
    <a rid="B37-cells-09-00094" ref-type="bibr">37</a>, 
    <a rid="B38-cells-09-00094" ref-type="bibr">38</a>, 
    <a rid="B44-cells-09-00094" ref-type="bibr">44</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TRPV4</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of TRPV4- releases DDX3X and promote the viral RNA metabolism [ 
    <a rid="B52-cells-09-00094" ref-type="bibr">52</a>]. 
   </td>
  </tr>
  <tr>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NMDAr</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV, JEV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NMDAr contributes to ZIKA by triggering the neuronal cell death progress [ 
    <a rid="B58-cells-09-00094" ref-type="bibr">58</a>, 
    <a rid="B60-cells-09-00094" ref-type="bibr">60</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increases Ca 
    <sup>2+</sup> influx [ 
    <a rid="B62-cells-09-00094" ref-type="bibr">62</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IP 
    <sub>3</sub>R 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1, HSV, HRV, and HCMV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">These viral proteins deplete ER Ca 
    <sup>2+</sup> store during early stages of viral infection to increase the replication ability of viruses [ 
    <a rid="B37-cells-09-00094" ref-type="bibr">37</a>, 
    <a rid="B62-cells-09-00094" ref-type="bibr">62</a>, 
    <a rid="B63-cells-09-00094" ref-type="bibr">63</a>, 
    <a rid="B64-cells-09-00094" ref-type="bibr">64</a>, 
    <a rid="B66-cells-09-00094" ref-type="bibr">66</a>]. 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SPCA1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RSV, ZIKV, DENV and WNV</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trigger to produce functional viral glycoproteins that are essential for virus spread [ 
    <a rid="B70-cells-09-00094" ref-type="bibr">70</a>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>Abbreviations: Influenza A virus (IAV), Severe fever with thrombocytopenia syndrome virus (SFTSV), New world hemorrhagic fever arenaviruses (NWV), Japanese encephalitis virus (JEV), Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV), Herpes simplex virus (HSV)-1, Ebolavirus (EBOV), Marburgvirus (MARV), Lassa Virus (LASV), Junín Virus (JUNV), Hepatitis B virus (HBV), Respiratory syncytial virus (RSV), Human rhinovirus (HRV), and Human cytomegalovirus (HCMV). Voltage-gated calcium channels (VGCCs), Two-pore channels (TPCs), Stromal interaction molecule 1 (STIM1), Transient receptor potential vanilloid 4 (TRPV4), N-methyl-D-aspartate receptor (NMDAR), IP 
    <sub>3</sub> receptor (IP 
    <sub>3</sub>R), Secretory pathway Ca 
    <sup>2+</sup>-ATPase (SPCA1). DEAD-box RNA helicase (DDX3X), Endoplasmic reticulum (ER). 
   </p>
  </p>
 </tfoot>
</table>
